• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.

作者信息

Mariani G, Scheibel E, Nogao T, Kasper C K, Ewing N P, Mauser-Bunschoten E, Ghirardini A, Bellocco R, Brackman H H

机构信息

Department of Human Biopathology, University of Rome La Sapienza, Italy.

出版信息

Semin Hematol. 1994 Apr;31(2 Suppl 4):62-4.

PMID:7939781
Abstract
摘要

相似文献

1
Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.免疫耐受作为血友病中针对凝血因子VIII同种抗体的治疗方法。免疫耐受方案国际登记处。
Semin Hematol. 1994 Apr;31(2 Suppl 4):62-4.
2
Inhibitors of factor VIII: detection and treatment.凝血因子VIII抑制剂：检测与治疗
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:21-5.
3
Antibodies to factor VIII in hemophilia A patients.甲型血友病患者中针对凝血因子VIII的抗体。
Vox Sang. 2000;78 Suppl 2:187-90.
4
Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.血友病因子VIII治疗。免疫耐受。临床视角。
Haematologica. 2000 Oct;85(10 Suppl):113-6.
5
[Hemophilia A with factor VIII inhibitor].[伴VIII因子抑制物的甲型血友病]
Rinsho Ketsueki. 2003 Feb;44(2):90-101.
6
The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.甲型和乙型血友病成功诱导免疫耐受后的耐受性维持：北美登记处。国际血栓与止血协会因子VIII/IX小组委员会。
Haematologica. 2000 Oct;85(10 Suppl):40-2; discussion 42-4.
7
Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.伴有凝血因子VIII抑制物的血友病中的免疫耐受：成功的预测因素
Haematologica. 2001 Nov;86(11):1186-93.
8
The North American Immune Tolerance Registry: practices, outcomes, outcome predictors.北美免疫耐受登记处：实践、结果及结果预测因素
Thromb Haemost. 2002 Jan;87(1):52-7.
9
Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.血友病中的免疫耐受——国际注册研究的主要结果。凝血因子VIII和IX小组委员会报告。
Thromb Haemost. 1994 Jul;72(1):155-8.
10
The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy.北美免疫耐受登记处：对免疫耐受治疗三十年经验的贡献。
Haemophilia. 2009 Jan;15(1):320-8. doi: 10.1111/j.1365-2516.2008.01880.x. Epub 2008 Oct 30.

引用本文的文献

1
Exploration of biomarkers for inhibitor development in persons with hemophilia A.血友病A患者中用于抑制剂开发的生物标志物探索。
Res Pract Thromb Haemost. 2025 Apr 27;9(4):102877. doi: 10.1016/j.rpth.2025.102877. eCollection 2025 May.
2
Differential genes expression of immune tolerance induction in hemophilia A: an exploratory RNA-seq test from a Chinese hemophilia comprehensive care centre.甲型血友病免疫耐受诱导中的差异基因表达：来自中国血友病综合治疗中心的探索性RNA测序测试
Transl Pediatr. 2024 Dec 31;13(12):2110-2117. doi: 10.21037/tp-24-300. Epub 2024 Dec 27.
3
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial.
BAY 81-8973 在未经治疗和轻度治疗的严重血友病 A 儿童中的疗效和安全性：LEOPOLD Kids 试验。
Thromb Haemost. 2023 Jan;123(1):27-39. doi: 10.1055/s-0042-1757876. Epub 2023 Jan 10.
4
Management of haemophilia A with inhibitors: A regional cross-talk.血友病 A 伴抑制物的治疗：区域间对话。
Haemophilia. 2022 Nov;28(6):950-961. doi: 10.1111/hae.14638. Epub 2022 Jul 22.
5
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.随着emicizumab 的出现，血友病 A 免疫耐受诱导的面貌正在发生变化。
Haemophilia. 2019 Jul;25(4):676-684. doi: 10.1111/hae.13762. Epub 2019 Apr 29.
6
Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.基于基因的 FVIIa 预防治疗可调节血友病 A 大鼠的自发性出血表型。
Blood Adv. 2019 Feb 12;3(3):301-311. doi: 10.1182/bloodadvances.2018027219.
7
Early eradication of factor VIII inhibitor in patients with congenital hemophilia A by immune tolerance induction with a high dose of immunoglobulin.通过大剂量免疫球蛋白诱导免疫耐受，早期根除先天性血友病A患者体内的凝血因子VIII抑制物。
Int J Hematol. 2016 Apr;103(4):473-7. doi: 10.1007/s12185-016-1943-0. Epub 2016 Feb 1.
8
Factor VIII inhibitors in hemophilia A: rationale and latest evidence.因子 VIII 抑制剂在血友病 A 中的应用：原理和最新证据。
Ther Adv Hematol. 2013 Feb;4(1):59-72. doi: 10.1177/2040620712464509.
9
Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.
Clin Rev Allergy Immunol. 2009 Oct;37(2):125-34. doi: 10.1007/s12016-009-8115-4.
10
Management of factor VIII inhibitors.VIII因子抑制剂的管理
Int J Hematol. 2006 Feb;83(2):119-25. doi: 10.1532/IJH97.05129.